New Fragrance Laws are Nothing to Sneeze At

𝘍𝘰𝘳 𝘢𝘭𝘭𝘦𝘳𝘨𝘺 𝘴𝘶𝘧𝘧𝘦𝘳𝘦𝘳𝘴, 𝘵𝘩𝘦 𝘯𝘦𝘸 𝘳𝘶𝘭𝘦𝘴 𝘤𝘰𝘶𝘭𝘥 𝘣𝘦 𝘭𝘪𝘧𝘦-𝘴𝘢𝘷𝘪𝘯𝘨. 𝘍𝘰𝘳 𝘪𝘯𝘥𝘦𝘱𝘦𝘯𝘥𝘦𝘯𝘵 𝘱𝘦𝘳𝘧𝘶𝘮𝘦𝘳𝘴, 𝘵𝘩𝘦𝘺 𝘤𝘰𝘶𝘭𝘥 𝘣𝘦 𝘦𝘹𝘪𝘴𝘵𝘦𝘯𝘵𝘪𝘢𝘭.⁣⁣

For fragrance enthusiasts and independent perfumers, a masterfully composed scent is an invisible piece of architecture, built from raw materials that shift and breathe on the skin over hours. For decades, the trade secrets behind these liquid arts were guarded on packaging by a single, legally protected word: parfum.⁣⁣
⁣⁣
But fragrance, atomized into shared spaces, cannot remain a private art. That collision, between consumer safety and artistic tradition, is now reaching a reckoning.⁣⁣
⁣⁣
Consider the elementary school teacher based in Ontario who lives with anaphylactic allergies to fragrance so severe that a stranger’s perfume on a transit bus once sent her gasping onto the sidewalk three stops early. Standing at the front of her classroom, a student sprayed a cheap body mist as a prank “to see what would happen.” She couldn’t breathe, and the afternoon ended with an ambulance and emergency adrenaline.⁣⁣
⁣⁣
“Any legislation that brings people’s attention to how they’re affecting others could literally save my life,” she told me, speaking on condition of anonymity.⁣⁣
⁣⁣
Amrit Judge, an equipment operator in the transportation sector based in Surrey, British Columbia, and an active member of the Canadian Fragrance Enthusiasts community on Facebook, navigates a less extreme version of the same problem. For him, exposure rarely announces itself clearly. “One of the biggest challenges isn’t just avoiding certain perfumes,” he told me. “It’s not knowing exactly what I’m reacting to.”⁣⁣
⁣⁣
On July 31, 2026, a regulatory framework set into motion more than a decade ago finally arrives in force across the European Union. It speaks with unsettling precision to exactly what both of them described to me. Yet what little trade coverage exists has largely filed it under compliance news, a dry line item for corporate counsel to circle in red.⁣⁣
⁣⁣
That framing is a mistake. The real story here is about the changing boundaries of an art form: who gets to be transparent, and who can actually afford the price of admission.⁣⁣

𝐖𝐡𝐚𝐭 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐜𝐡𝐚𝐧𝐠𝐞𝐝, 𝐚𝐧𝐝 𝐰𝐡𝐲 𝐢𝐭 𝐭𝐨𝐨𝐤 𝐬𝐨 𝐥𝐨𝐧𝐠⁣⁣

The regulation itself is Commission Regulation (EU) 2023/1545. Cosmetic labels in Europe used to be required to individually name 24 fragrance allergens. As of this month, that number expands to 81, a sweeping addition of substances previously permitted to hide beneath the word “parfum,” now printed explicitly for the first time.⁣⁣
⁣⁣
If you look for a dramatic catalyst, a corporate scandal, a product recall or a viral health crisis that forced the European Commission’s hand, you won’t find one. The Scientific Committee on Consumer Safety identified 56 additional substances in 2012 (regulators and industry trackers cite slightly different final totals, a discrepancy I couldn’t fully reconcile), findings that took eleven years to become binding law, and three more before the deadline arrived. If there is a smouldering scandal buried here, it is the drag of bureaucratic time itself: a known risk sitting on a shelf for over a decade before anyone was required to say so out loud.⁣⁣
⁣⁣
Products that don’t yet comply may still be placed on the EU market until July 31, 2026. Anything already on a shelf may be sold until July 31, 2028, before it, too, must comply or disappear from shelves.⁣⁣

𝐓𝐡𝐞 𝐧𝐮𝐦𝐛𝐞𝐫 𝐧𝐨𝐛𝐨𝐝𝐲 𝐞𝐱𝐩𝐥𝐚𝐢𝐧𝐬 𝐩𝐫𝐨𝐩𝐞𝐫𝐥𝐲⁣⁣

Buried in the regulation’s own text is an estimate that 1-9% percent of the European population is allergic to fragrance allergens. It’s a strange, wide range to read in a legal document, and it deserves an honest explanation.⁣⁣
⁣⁣
The honest answer is that “fragrance allergen” was never a single thing. It’s a category of 81 different substances, each with its own rate of causing a reaction, spread across 27 countries with different populations, measured in some cases by a positive reaction in a dermatologist’s patch test and in other cases by whether someone simply noticed a rash after wearing a new cologne. A range that wide might seem imprecise, but it’s what happens when you try to put one number on something that was never singular to begin with.⁣⁣
⁣⁣
The same 2020 impact assessment behind that figure puts a price on what inaction costs, and the number worth remembering is a human-scaled one. Consumers with fragrance allergies, the study found, were spending somewhere between 100 and 500 euros a year, split between direct medical costs and the out-of-pocket price of specialized, allergen-free products. Multiply that per-person range across an estimated 20.5 million affected Europeans, and the study’s own aggregate lands between 4 billion and 20 billion euros a year, a wide spread, but one that comes from how differently people’s own spending varies, not from any real uncertainty about how many people are affected. That’s the backdrop against which every argument over labeling, packaging, and compliance cost that follows actually plays out.⁣⁣

𝐓𝐡𝐞 𝐨𝐧𝐞𝐬 𝐰𝐡𝐨 𝐰𝐢𝐥𝐥 𝐟𝐞𝐞𝐥 𝐭𝐡𝐢𝐬 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭⁣⁣

Here is the part of the story I don’t believe has been told elsewhere: this regulation does not fall evenly.⁣⁣
⁣⁣
A fragrance built from a wide, complex constellation of essential oils, the kind of formula a niche or artisanal house often prizes precisely because it smells like nothing else on a department store shelf, is more likely to contain several of these newly named allergens than a simpler, synthetic-forward formula built by a conglomerate’s in-house lab. Many of these substances occur naturally in the raw ingredients that give niche perfumery its depth. The European Commission’s own impact assessment on this exact regulation confirms as much: companies working with natural ingredients, it found, are often unable to reduce the number of labeled allergens in their formulas, since those substances are simply too frequently present in natural extracts to begin with. That’s not a case against natural perfumery. It is simply a structural fact about it, and one this regulation happens to land hardest on.⁣⁣
⁣⁣
A company with a standing regulatory affairs department absorbs a change like this the way a large ship absorbs a wave. A founder working alone, or with two or three people, absorbs it the way a person standing in that same wave does.⁣⁣

𝐒𝐦𝐚𝐥𝐥𝐞𝐫 𝐛𝐫𝐚𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞𝐢𝐫 𝐨𝐰𝐧 𝐰𝐨𝐫𝐝𝐬⁣⁣

George Zaharoff, who owns the Chicago-based niche fragrance house that bears his surname, shared his perspective on the deadline over Facebook Messenger.⁣⁣
⁣⁣
“The July 31 allergen-labeling deadline is less about changing how we formulate fragrances and more about raising the standard for transparency and documentation,” he said. “As an independent house, we don’t have the size of a global conglomerate, but we’ve approached compliance as an investment rather than an obstacle.”⁣⁣
⁣⁣
For months, he said, his team has worked alongside MANE, the fragrance house that supplies his formulas, rebuilding the brand’s regulatory library: allergen declarations, IFRA documentation, safety data sheets, ingredient listings, full manufacturing formulas and packaging. “It’s been a considerable amount of work,” he said, “but it’s also strengthened the foundation of the brand.”⁣⁣
⁣⁣
Zaharoff’s fragrances draw from Mediterranean citrus, Middle Eastern resins, Egyptian themes and Japanese incense traditions, a global palette now required to answer to a distinctly European standard. He doesn’t see this as a contradiction. “Good compliance doesn’t diminish creativity,” he said. “It allows that creativity to be shared confidently in more markets.”⁣⁣
⁣⁣
He also pointed to a structural observation rather than a complaint. “Large organizations often have dedicated regulatory departments,” he said. “Independent brands frequently rely on founders who wear many hats. That can make regulatory changes more challenging, but it also gives us a much deeper understanding of every aspect of what we create.”⁣⁣
⁣⁣
From Italy, Lucas Chemelli, a partner at Lussur, an Italian company whose work spans premium perfume alongside textiles and glassware rather than fragrance alone, offered a similarly measured response, translated from Italian. “We welcome the new European regulation on perfume labeling with a sense of responsibility and will fully comply with it,” he said, “because we believe that consumer protection, transparency, and compliance are fundamental values for those who operate seriously in the sector.” But he was direct about what that welcome actually costs in practice: reprinting labels, revising packaging, managing existing stock, and, in his words, “a significant investment in time and financial resources.” For a large group, he said, those changes “can be more easily absorbed,” while for a small or medium-sized business, “the impact on daily operations is direct and immediate.”⁣⁣
⁣⁣
Chemelli raised something no one else in this piece had: an environmental cost sitting quietly inside the compliance cost. “There is a real risk of having to replace materials that are still perfectly usable,” he said, “resulting in waste and impacting environmental sustainability.” His hope, he said, is that future implementation finds a way to hold safety and transparency standards high while still building in “proportionate and truly sustainable” methods for smaller businesses, rather than applying one set of expectations evenly regardless of company size.⁣⁣

𝐖𝐡𝐚𝐭 𝐭𝐡𝐞 𝐥𝐚𝐛𝐞𝐥 𝐢𝐬 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐟𝐨𝐫⁣⁣

It’s worth returning, before this piece ends, to the two people who opened it.⁣⁣
⁣⁣
Fragrance, Judge reminded me, is not only confined to a bottle marked “parfum”. It hides in soaps, detergent, fabric softener, candles, air freshener and hand lotion. Living with an allergy to it means reading labels constantly, and sometimes it means avoiding an environment altogether.⁣⁣
⁣⁣
He also raised a concern connected to the independent-brand side of this story: the rise of copycat fragrances, known as clones or dupes.⁣⁣
⁣⁣
“Some smaller or lesser-known brands provide very little transparency about where their raw materials come from or exactly which fragrance ingredients are being used,” he said. “If I’m reacting to a particular allergen, I need to know what’s actually in the bottle.” For Judge, this isn’t an argument against affordability or against perfume as an art form.⁣⁣
⁣⁣
“It’s not about discouraging people from wearing perfume or criticizing affordable alternatives,” he said. “It’s about giving consumers, especially those with allergies, the information they need to identify potential triggers.”⁣⁣
⁣⁣
For the Ontario teacher, the stakes sit at a different altitude: a reaction is not something managed quietly at home, and it has meant, more than once, an ambulance and adrenaline. Neither she nor Judge lives in the European Union, and the rule described here does not, strictly speaking, govern either of their countries. And yet everything they described to me is precisely the harm this regulation exists to prevent.⁣⁣

𝐀 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧 𝐝𝐞𝐭𝐚𝐢𝐥 𝐭𝐡𝐚𝐭 𝐝𝐞𝐬𝐞𝐫𝐯𝐞𝐬 𝐦𝐨𝐫𝐞 𝐚𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐭𝐡𝐚𝐧 𝐢𝐭’𝐬 𝐠𝐨𝐭𝐭𝐞𝐧⁣⁣

Canada is doing nearly the same thing, on nearly the same timeline, by design. I haven’t seen this connection reported elsewhere.⁣⁣

Health Canada finalized its own amended Cosmetic Regulations (SOR/2024-63) in April 2024, requiring Canadian labels to name fragrance allergens individually, with the general legal framework coming into force April 12, 2026. Health Canada’s own published guidance confirms the expanded list, which it describes as growing “from 24 to 81 entries,” applies to new products starting August 1, 2026, and to existing products starting August 1, 2028. Written into the regulation is a mechanism Health Canada calls “ambulatory incorporation by reference,” tying the substance of what must be disclosed to the EU’s own evolving list.⁣⁣
⁣⁣
Health Canada’s own impact analysis puts the price tag at 2.66 million CAD a year in industry-wide compliance costs, a figure worth putting in proportion. Canada’s cosmetics market is worth an estimated 11.7 billion CAD a year, making 2.66 million CAD a small fraction of the whole. But the government’s own survey data suggests that smallness is deceptive. Of 123 companies that responded to Health Canada’s cost-benefit survey, annual sales ranged from under 1,000 CAD a year to more than 100 million CAD, together representing about 2 billion CAD of that 11.7 billion CAD market. Of 114 companies that answered whether they already disclosed the original 24 allergens, only a third said yes. When suppliers were surveyed again after the list expanded to match the EU’s, the estimated share of cosmetics actually affected rose from roughly 5% to roughly 15%, meaning some 85% of surveyed companies’ sales were already unaffected, either because they were already compliant, didn’t use the substances in question, or already met the EU’s own requirement.⁣⁣
⁣⁣
The burden, in other words, isn’t spread evenly; it’s concentrated on a minority of companies and products, the same minority this piece has been describing all along. Health Canada’s own analysis doesn’t draw that conclusion explicitly, but the data does it for them.⁣⁣
⁣⁣
During the public consultation, several industry voices objected specifically to tying Canadian law to a foreign regulator’s timeline without a parallel Canadian process. Health Canada’s answer was that the approach is lawful, and that the EU’s own rulemaking is, at least in principle, open to anyone who wants to weigh in.⁣⁣
⁣⁣
For people suffering from fragrance allergies in Canada, this means the protection they described wanting is arriving in their own country too, on a timeline borrowed from somewhere else.⁣⁣

𝐓𝐡𝐞 𝐜𝐨𝐮𝐧𝐭𝐫𝐲 𝐭𝐡𝐚𝐭 𝐰𝐫𝐨𝐭𝐞 𝐭𝐡𝐞 𝐥𝐚𝐰 𝐚𝐧𝐝 𝐭𝐡𝐞𝐧 𝐰𝐚𝐢𝐭𝐞𝐝⁣⁣

If the European Union has a hard deadline, and Canada has a borrowed one, the United States, remarkably, has neither, despite a law that has required action since 2022.⁣⁣
⁣⁣
The Modernization of Cosmetics Regulation Act gave the FDA a statutory deadline of June 29, 2024, to propose its own fragrance allergen rule. That date passed without action. So did the next one, and the one after that. As of this writing, the agency’s own live regulatory agenda lists a new target of November 2026, at least the fourth known target date since the original statutory deadline.⁣⁣
⁣⁣
There’s a further wrinkle, confirmed directly in the FDA’s own regulatory filing: the agency has stated it is weighing an alternative approach entirely, a more general allergen statement rather than the EU’s model of individually naming each of the 81 substances. In the agency’s own words, from its Unified Agenda filing, “FDA will also consider an alternative labeling requirement, such as a more general allergen statement,” while noting the expected benefits of that softer approach would likely be lower. If the FDA goes this route once it finally acts, the US may end up with a fundamentally different, less granular disclosure standard than the EU and Canada, not simply a delayed copy of it.⁣⁣
⁣⁣
As of July 2026, no proposed rule has been published. The agency’s own current Agenda Stage confirms it: still “Proposed Rule Stage,” not yet issued. A law passed by Congress requiring action has now gone unanswered for over four years, its own deadline slipping repeatedly, while the country that inspired it crosses its own finish line this month.⁣⁣

𝐀𝐧 𝐞𝐧𝐝𝐢𝐧𝐠 𝐭𝐡𝐚𝐭 𝐢𝐬𝐧’𝐭 𝐫𝐞𝐚𝐥𝐥𝐲 𝐚𝐧 𝐞𝐧𝐝𝐢𝐧𝐠⁣⁣

July 31 will come and go, and the story will not be over. The sell-through deadline waits until 2028. By then, Canada’s timeline will have caught up to Europe’s, the United States may finally have written the rule it promised its own citizens years ago, and the small, founder-run houses navigating all of this in real time, the ones without a department for this, will have spent years quietly paying a cost that the largest names in this industry barely felt.⁣⁣
⁣⁣
For the woman in the Ontario classroom, and for Amrit Judge, none of this is theoretical. It is the difference between a label that tells them the truth, and one that leaves them to find out the hard way.⁣⁣
⁣⁣
𝘈𝘭𝘪 𝘉𝘰𝘬𝘩𝘢𝘳𝘪 𝘪𝘴 𝘵𝘩𝘦 𝘍𝘰𝘶𝘯𝘥𝘦𝘳 𝘢𝘯𝘥 𝘌𝘥𝘪𝘵𝘰𝘳-𝘪𝘯-𝘊𝘩𝘪𝘦𝘧 𝘰𝘧 𝘈𝘭𝘪 𝘗𝘦𝘳𝘧𝘶𝘮𝘦𝘸𝘢𝘭𝘢.⁣⁣

𝐄𝐧𝐝𝐧𝐨𝐭𝐞𝐬⁣⁣

1. Commission Regulation (EU) 2023/1545 of 26 July 2023, amending Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in cosmetic products. Official Journal of the European Union, L 188, 27 July 2023. Available at: https://eur-lex.europa.eu/eli/reg/2023/1545/oj/eng⁣⁣
   ⁣⁣
2. Scientific Committee on Consumer Safety, opinion on fragrance allergens in cosmetic products (SCCS/1459/11), adopted at the SCCS plenary meeting of 26-27 June 2012. Cited directly within the recitals of Regulation (EU) 2023/1545 (see note 1).⁣⁣
   ⁣⁣
3. The estimate that 1-9% of the EU population is allergic to fragrance allergens appears in recital (2) of Regulation (EU) 2023/1545 (see note 1), which cites: “Impact assessment study on fragrance labelling on cosmetic products,” commissioned by the European Commission’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (VVA, Ecorys, and ConPolicy, November 2020). That study in turn traces the 1-9% estimate to a specific peer-reviewed source: Alinaghi, F., et al. (2019). “Prevalence of contact allergy in the general population: A systematic review and meta-analysis.” Contact Dermatitis, 80(2), 77-85. doi:10.1111/cod.13119. This same 2020 impact assessment study is also the source for the EUR 4-20 billion annual consumer cost estimate and the finding that natural-ingredient formulations cannot easily reduce their allergen count, both cited in this piece.⁣⁣
   ⁣⁣
4. Health Canada, Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients (SOR/2024-63). Canada Gazette, Part II, 24 April 2024. Available at: https://gazette.gc.ca/rp-pr/p2/2024/2024-04-24/html/sor-dors63-eng.html. The confirmed August 1, 2026 and August 1, 2028 dates, and the “24 to 81 entries” figure, come from Health Canada’s own published guidance: “Industry Guide for the labelling of cosmetics,” available at canada.ca (Health Canada, Consumer Product Safety). Note: this piece uses 81 as the total, per Health Canada’s own count, though the EU regulation’s own recital text (24 existing plus 56 additional) totals 80 by simple arithmetic, a discrepancy that could not be fully reconciled.⁣⁣
   ⁣⁣
5. U.S. Food and Drug Administration, Unified Agenda entry for RIN 0910-AI90, “Disclosure of Fragrance Allergens in Cosmetic Labeling,” current live entry (Publication ID: 2026), confirming Agenda Stage as “Proposed Rule Stage” and a revised NPRM target of November 2026. Available at: https://www.reginfo.gov/public/do/eAgendaViewRule?RIN=0910-AI90. Agency contact listed: Elizabeth Anderson, Senior Policy Analyst, FDA Office of the Chief Scientist.⁣⁣
   ⁣⁣
6. George Zaharoff, owner, Zaharoff Fragrances, personal interview conducted via Facebook Messenger, July 6, 2026.⁣⁣
   ⁣⁣
7. Amrit Judge, member, Canadian Fragrance Enthusiasts community, personal interview conducted via Facebook, July 6, 2026.⁣⁣
   ⁣⁣
8. Anonymous source, elementary school teacher, Ontario, Canada, personal interview conducted via Facebook, name withheld at source’s request, July 6, 2026.⁣⁣
   ⁣⁣
9. Lucas Chemelli, partner, Lussur, personal interview conducted via WhatsApp, received July 11, 2026. Original comments provided in Italian; translated via Google Translate and verified for accuracy by a native Italian speaker. Quoted here as a translation, not Chemelli’s original words verbatim.⁣⁣
   ⁣⁣